Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Willwerth Christina Insider Profile
4 Followers
Willwerth Christina, CSO at Flexion Therapeutics, holds 121.79K shares in Flexion Therapeutics (Ticker: FLXN).
Willwerth Christina has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Willwerth Christina's holdings
Insider Roles
CSO
Roles that Willwerth Christina holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 14, 2019 - Aug 14, 2020
Return:+11.60%
The most profitable trade made by Willwerth Christina
Willwerth Christina's Trading History
List of latest transactions for each holding click on a transaction to see Willwerth Christina's performance on stock
You May Also Like
Willwerth Christina insider profile FAQ
What is the percentage of profitable transactions made by Willwerth Christina?
The percentage of profitable transactions made by Willwerth Christina is ―.
What is the average return per transaction made by Willwerth Christina?
The average return per transaction made by Willwerth Christina is ―.
What stocks does Willwerth Christina hold?
Willwerth Christina holds: FLXN stocks.
What was Willwerth Christina’s latest transaction?
Willwerth Christina latest transaction was an Uninformative Buy of ―.
What was Willwerth Christina's most profitable transaction?
Willwerth Christina’s most profitable transaction was an Informative Buy of FLXN stock on August 14, 2019. The return on the trade was 11.60%.
What is Willwerth Christina's role in Flexion Therapeutics?
Willwerth Christina's role in Flexion Therapeutics is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.